Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Willow Biosciences Inc T.WLLW

Alternate Symbol(s):  CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.


TSX:WLLW - Post by User

Post by Stretchon Mar 28, 2021 10:27pm
171 Views
Post# 32896326

Radius Research Anyone can find a video or audio pls post

Radius Research Anyone can find a video or audio pls post

 

custom banner
Willow Biosciences Inc. (WLLW) - Fri Mar 26 - 10am PT / 1pm ET

Mar 26, 2021 10:00 AM

Pacific Time (US and Canada)

CEO Trevor Peters of Willow Biosciences will be presenting.

Through yeast bio-synthesis, Willow's research and development group has developed numerous cannabinoids from proprietary yeast strains, including THC and CBG. 

Willow is a Canadian biotechnology company based in Vancouver, B.C., that produces high-purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. 

Willow's current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow's science team has a proven record of developing manufacturing technologies for high-purity compounds in pain and cancer treatments. 

Willow's manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life-changing drugs.

<< Previous
Bullboard Posts
Next >>